Fortress Biotech, Inc.
NASDAQ:FBIO
2.08 (USD) • At close January 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Fortress Biotech, Inc. |
Symbool | FBIO |
Munteenheid | USD |
Prijs | 2.08 |
Beurswaarde | 57,418,192 |
Dividendpercentage | 0% |
52-weken bereik | 1.36 - 2.89 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Lindsay Allan Rosenwald |
Website | https://www.fortressbiotech.com |
An error occurred while fetching data.
Over Fortress Biotech, Inc.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)